EC to update IP rules to benefit generic exports
biosimilar, biosimilars Europe, EC, EU, European Commission, European pharma, generics, pharma IP, Pharma regulation
0 Comment
The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets.
